Clinical Trial Update: A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating the effectiveness and tolerability of MK-8141 in adults with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-8141

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 2 | Status: COMPLETED